VA Health Care:
Continuing Oversight Needed to Achieve Formulary Goals
GAO-01-998T: Published: Jul 24, 2001. Publicly Released: Jul 24, 2001.
Additional Materials:
- Full Report:
Contact:
(202) 512-7207
contact@gao.gov
Office of Public Affairs
(202) 512-4800
youngc1@gao.gov
Although the Department of Veterans Affairs (VA) has made significant progress establishing a national formulary that has generally met with acceptance by prescribers and patients, VA oversight has not fully ensured standardization of its drug benefit nationwide. The three medical centers GAO visited did not comply with the national formulary. Specifically, two of the three medical centers omitted more than 140 required national formulary drugs, and all three facilities inappropriately modified the national formulary list of required drugs for certain drug classes by adding or omitting some drugs. In addition, as VA policy allows, Veterans Integrated Service Networks (VISN) added drugs to supplement the national formulary ranging from five drugs at one VISN to 63 drugs at another. However, VA lacked criteria for determining the appropriateness of the actions networks took to add these drugs. In addition to problems standardizing the national formulary, GAO identified weaknesses in the nonformulary approval process. Although the national formulary directive requires certain criteria for approving nonformulary drugs, it does not prescribe a specific nonformulary approval process. As a result, the processes health care providers must follow to obtain nonformulary drugs differ among VA facilities on how requests are made, who receives them, who approves them, and how long it takes to obtain approval. GAO found that the length of time to approve nonformulary drugs averages nine days, but it can be as short as a few minutes in some medical centers. Some VISNs have not established processes to collect and analyze data on nonformulary requests. As a result, VA does not know if approved requests meet its established criteria or if denied requests are appropriate. This testimony summarizes the December 1999 report, HEHS-00-34 and the January 2001 report, GAO-01-183.
Jan 14, 2021
-
Prescription Drugs:
Department of Veterans Affairs Paid About Half as Much as Medicare Part D for Selected Drugs in 2017GAO-21-111: Published: Dec 15, 2020. Publicly Released: Jan 14, 2021.
Dec 10, 2020
-
VA Construction:
VA Should Enhance the Lessons-Learned Process for Its Real-Property Donation Pilot ProgramGAO-21-133: Published: Dec 10, 2020. Publicly Released: Dec 10, 2020.
Dec 9, 2020
-
VA Disability Benefits:
Process for Identifying Conditions Presumed to be Service Connected and Challenges in Processing Complex Gulf War Illness ClaimsGAO-21-253T: Published: Dec 9, 2020. Publicly Released: Dec 9, 2020.
Nov 12, 2020
-
Veterans Health Care:
Agency Efforts to Provide and Study Prosthetics for Small but Growing Female Veteran PopulationGAO-21-60: Published: Nov 12, 2020. Publicly Released: Nov 12, 2020.
Sep 30, 2020
-
VA Health Care:
Additional Steps Could Help Improve Community Care Budget EstimatesGAO-20-669: Published: Sep 30, 2020. Publicly Released: Sep 30, 2020. -
Veterans Community Care Program:
Improvements Needed to Help Ensure Timely Access to CareGAO-20-721T: Published: Sep 30, 2020. Publicly Released: Sep 30, 2020.
Sep 28, 2020
-
Veterans Community Care Program:
Improvements Needed to Help Ensure Timely Access to CareGAO-20-643: Published: Sep 28, 2020. Publicly Released: Sep 28, 2020.
Sep 21, 2020
-
VA Disability Benefits:
VA Should Continue to Improve Access to Quality Disability Medical Exams for Veterans Living AbroadGAO-20-620: Published: Sep 21, 2020. Publicly Released: Sep 21, 2020.
Sep 16, 2020
-
VA Acquisition Management:
COVID-19 Response Strains Supply Chain While Modernization Delays ContinueGAO-20-716T: Published: Sep 16, 2020. Publicly Released: Sep 16, 2020.
Sep 9, 2020
-
Veteran Suicide:
VA Needs Accurate Data and Comprehensive Analyses to Better Understand On-Campus SuicidesGAO-20-664: Published: Sep 9, 2020. Publicly Released: Sep 9, 2020.
Looking for more? Browse all our products here